Coya Therapeutics, Inc. (COYA)
2.80
-0.01
(-0.36%)
USD |
NASDAQ |
Nov 06, 10:15
Coya Therapeutics Gross Profit Margin (Quarterly) : 98.85% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 98.85% |
| March 31, 2026 | 98.88% |
| December 31, 2025 | 99.83% |
| September 30, 2025 | 99.81% |
| June 30, 2025 | 95.84% |
| March 31, 2025 | 97.32% |
| Date | Value |
|---|---|
| December 31, 2024 | -245.0% |
| September 30, 2024 | |
| June 30, 2024 | 99.80% |
| March 31, 2024 | 94.64% |
| December 31, 2023 | 99.89% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -56.77% |
| Return on Assets | -50.16% |
| Return on Invested Capital | -56.77% |
| Profit Margin (Quarterly) | -2.72K% |
| Operating Margin (Quarterly) | -2.89K% |
| Return on Net Operating Assets | -631.2% |